byiShook Opinion
Apr 14, 2025 - 08:40
Pfizer said Monday it's scrapping development of its daily weight-loss pill, danuglipron, after a patient experienced a liver injury. The post Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury appeared first on Investor's Business Daily.
Pfizer said Monday it's scrapping development of its daily weight-loss pill, danuglipron, after a patient experienced a liver injury.
The post Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury appeared first on Investor's Business Daily.